Skip to main content

Senate Bill

S. 1894

119th Congress

SPEED Act

In Committee
Introduced:Jun 10, 2025

Primary Sponsor

Cynthia M. Lummis

Cynthia M. Lummis

Senator

Republican
WY

Cosponsors

0

Quick Stats

Policy Area

Health

Summary

The SPEED Act would eliminate Medicare coinsurance requirements for colorectal cancer screening tests starting in 2023, rather than 2030 as currently scheduled. This would make these important cancer screenings more affordable and accessible for Medicare recipients.

Latest Action

Read twice and referred to the Committee on Finance.

SponsorCynthia M. Lummis (R-WY)
Introduced6/10/2025
StatusRead twice and referred to the Committee on Environment and Public Works.
ChamberSenate
Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

SPEED Act

The SPEED Act would eliminate Medicare coinsurance requirements for colorectal cancer screening tests starting in 2023, rather than 2030 as currently scheduled. This would make these important cancer screenings more affordable and accessible for Medicare recip

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The SPEED Act would eliminate Medicare coinsurance requirements for colorectal cancer screening tests starting in 2023, rather than 2030 as currently scheduled. This would make these important cancer screenings more affordable and accessible for Medicare recipients.

Bill Number
1894
Sponsor
Cynthia M. Lummis (R-WY)
Introduced
6/10/2025
Status
Read twice and referred to the Committee on Environment and Public Works.
Policy Area
Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title
SPEED Act
Bill Number
1894
Sponsor
Cynthia M. Lummis (R-WY)
Status
Read twice and referred to the Committee on Environment and Public Works.
Introduced
6/10/2025
Summary
The SPEED Act would eliminate Medicare coinsurance requirements for colorectal cancer screening tests starting in 2023, rather than 2030 as currently scheduled. This would make these important cancer screenings more affordable and accessible for Medicare recipients.

Data from Congress.gov

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.